Companies›Commodities›Chemicals›Chemicals & Petrochemicals
NSE:FINEORG

FINE ORGANIC IND. LTD.

Chemicals › Chemicals & Petrochemicals
₹5,089.50
at close · 28 Oct 2026
▼ 7.00 (-0.14%)

Latest filings

Next results: Mon, 2 Nov · Financial Results
  1. Board meeting on Nov 2 to consider Q2 FY26 results · Results
  2. Trading window closed for Q2 FY27 results · Compliance
  3. Fine Organic: Promoter inter-se transfer of 1% shares via HUF partition · Ownership Changes
All filings ↓
Ask Nexa about FINE ORGANIC IND. LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

AI · written from filings

Manufactures specialty oleochemical-based additives that customers use at low inclusion rates (0.1-0.5%) in food, polymer, cosmetic and coating products. Sells to industrial buyers across India and overseas, with exports at 55% of FY26 revenue of ₹2,365.8 cr. Operates 7 manufacturing plants supported by 4 subsidiaries and 2 joint ventures, with all existing facilities running at near-full capacity and the Patalganga food additives plant ramping up to full utilisation in FY27. Raw materials, principally palm oil and vegetable oils, are the largest cost line at 60.9% of revenue, and prices have been pushed up by Indonesia and Malaysia biodiesel mandates; employee costs are 6.9% and other operating expenses 12.8% of revenue. Volume growth is constrained until the SEZ plant at JNPA commissions in H2 FY28 — a project with planned capex of ₹700-750 cr (₹192.5 cr spent to date). The international footprint is being widened through a proposed 80% acquisition of Oleofine Organics in Malaysia for ₹82.9 cr, a greenfield US plant on 160 acres in South Carolina, a Thailand JV and a new Dubai subsidiary. Management guides to a sustainable 18-20% EBITDA margin range.

Operating scale
Manufacturing plants
7 plantsFY26
Subsidiaries and JVs
4 subsidiaries, 2 joint venturesFY26
Exports share of revenue
55% (54.64%)FY26
SEZ plant capex (planned total)
₹700-750 crFY26-FY28
SEZ plant capex (spent to date)
₹192.5 crFY26
Malaysia acquisition
80% stake in Oleofine Organics BHD for ~₹82.9 crFY26
Who pays it
Industrial customers in food, polymer, cosmetic and coating end-markets, both domestic (India) and overseas
Biggest cost
Palm oil and vegetable oils (raw materials) at 60.9% of revenue
Kind of business
Specialty chemicals, capacity-constrained with elevated palm oil exposure
Where it sits
7 manufacturing plants in India with expansion underway into US, Malaysia, Thailand and the UAE/GCC
Market Cap
₹15,604 Cr
P / E (TTM)
35.6×
EV / EBITDA
24.3×
Div Yield
0.22%
Growth
15.9%▲
Revenue 5y CAGR
PAT +28.2% · EBITDA +22.9%
Quality
28.6%▲
ROCE (5y median)
ROE 21.4% (5y median) · margin 25.6%
Leverage
0.02·
Debt / Equity · low
Net cash ₹143 Cr
Revenue FY21→FY26
2.1×▲
Margin +7.0 pts
₹1,133 Cr → ₹2,366 Cr
Cash conversion
0.86×·
Operating cash ÷ profit · 5 yrs
₹1,821 Cr on ₹2,117 Cr
Moves on a normal day
1.03%·
Median daily move
Last 267 sessions · the yardstick for filing-day moves
Where it sits among 107 Specialty Chemicals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#71/99
P/B#79/99
ROCE#17/106
ROE#18/99
Debt / Equity#23/99
EBITDA margin#12/99
Revenue growth#60/94
Profit growth#62/92

Scorecard

Measured from the filed financials, judged against its Specialty Chemicals peers · as of FY26 — not investment advice

Strengths
Revenue compounding 16% a year over 5 years
Profit compounding 28% a year over 5 years
Returns on capital 28.6% (5-year median)
#17 of 106 in Specialty Chemicals on the latest reported figures
Debt at 0.02× equity
lower than 78% of its 99 Specialty Chemicals peers
Concerns
Nothing flagged in the filed numbers.

Charts

How has the market priced it — with filings on the timeline?

FINEORG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from FINE ORGANIC IND. LTD.'s filed financials and exchange disclosures

What does FINE ORGANIC IND. LTD. do?

FINE ORGANIC IND. LTD. is a Chemicals & Petrochemicals company listed on NSE and BSE, trading under the symbol FINEORG.

Is FINE ORGANIC IND. LTD. profitable?

Yes. Over the trailing twelve months FINE ORGANIC IND. LTD. reported a net profit of ₹438 Cr on revenue of ₹2,472 Cr.

Does FINE ORGANIC IND. LTD. pay a dividend?

Yes. The dividend yield is 0.22% at the current price. It paid out 8% of its profit as dividend in FY26.

Is FINE ORGANIC IND. LTD. debt-free?

On a net basis, yes. It reported borrowings of ₹45 Cr on its 31 Mar 2026 balance sheet, but holds ₹143 Cr more cash than debt.

Is FINE ORGANIC IND. LTD. expensive compared with its peers?

On trailing P/E, FINE ORGANIC IND. LTD. ranks 71 of 99 in Specialty Chemicals — cheaper than 29% of them, against an industry median of 23.1×. This is a position, not a valuation judgement.

How much does the FINE ORGANIC IND. LTD. share price move in a day?

On a typical session FINE ORGANIC IND. LTD. moves 1.03% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.

When are FINE ORGANIC IND. LTD.'s next results?

Financial Results on Mon, 2 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track FINE ORGANIC IND. LTD.'s announcements?

Every NSE and BSE filing by FINE ORGANIC IND. LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.